相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
常温,避光
- 克隆性:
单克隆
- 抗体名:
C1QBP / HABP1抗体
Antibody Type : Mouse Monoclonal Antibody ( Mouse mAb Service Platform )
克隆号 : 04
抗体宿主 : Mouse IgG2b
缓冲液 : 0.2 μm filtered solution in PBS, 5% trehalose may be added in some batches. Please read the hardcopy of COA or contact our customer service to confirm the formulation.
制备方法 : This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human C1QBP / HABP1 (rh C1QBP / HABP1; Catalog#11874-H08E; NP_001203.1; His 75-Gln 282). The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography.
C1QBP / HABP1抗体 Background
Complement component 1 Q subcomponent-binding protein, mitochondrial, also known as GC1q-R protein, Glycoprotein gC1qBP, Hyaluronan-binding protein 1, Mitochondrial matrix protein p32, p33 and C1QBP, is a nucleus protein which belongs to theMAM33 family. Human C1QBP (p33, p32, GC1q-R, TAP) is a ubiquitously expressed, multiligand-binding, multicompartmental cellular protein involved in various ligand-mediated cellular responses. C1QBP is known to bind to the globular heads of C1q molecules and inhibit C1 activation. This protein has also been identified as the p32 subunit of pre-mRNA splicing factor SF2, as well as a hyaluronic acid-binding protein. Although expressed on the surface of cells, an intriguing feature of the membrane-associated form of C1QBP is that its translated amino acid sequence does not predict the presence of either a sequence motif compatible with a transmembrane segment or a consensus site for a glycosylphosphatidylinositol anchor. Moreover, the N-terminal sequence of the pre-pro-protein C1QBP contains a motif that targets the molecule to the mitochondria and as such was deemed unlikely to be expressed on the surface. C1QBP also interacts with HIV-1 Tat.
C1QBP / HABP1抗体相关产品如下:xy-2274R HCMV UL49人巨细胞病毒UL49蛋白抗体
xy-8617R HNF1 beta肝细胞核因子1β/HNF-1β抗体
xy-15479R HHLA3HHLA3蛋白抗体
xy-15477R HHIPL2HHIP样蛋白2抗体
xy-10331R H3N2 Matrix Protein 2A型流感病毒H3N2-M2蛋白抗体
xy-13643R HSH2DHSH2D抗体
xy-4561R Hirudin水蛭素抗体
xy-10086R HLA Class 1 ABC白细胞抗原A抗体
xy-10202R HPV16 E7人乳头瘤病毒16型E7抗体
xy-10201R HPV58 E6人类乳头状瘤病毒58 E6蛋白抗体
xym-0990M HPV16 E6 protein人类乳头状瘤病毒16抗体
xy-10204R HPV18 E7人类乳头状瘤病毒18 E7抗体
xy-10203R HPV31 E7人类乳头状瘤病毒31 E7抗体
xy-12383R HES2转录因子HES2抗体
xy-12384R HES3转录因子HES3抗体
xy-12385R IPMK多磷酸肌醇激酶IPMK抗体
xy-13644R IKAPIKK复合物相关蛋白抗体
xy-13645R IQSEC2IQSEC2抗体
xy-13646R Intersectin 2交叉蛋白2抗体
xy-13590R Inosine triphosphate pyrophosphatase三磷酸肌苷焦磷酸酶抗体
xy-15493R IDO吲哚胺2,3-双加氧酶抗体
xy-10087R IL-19白细胞介素19抗体
xy-7130R Inhibin Alpha抑制素A/Inhibin α抗体
xy-7337R Islet-1+2胰岛素基因增强结合蛋白1/2抗体
xy-3192R Phospho-IRAK1 (Ser376)磷酸化白介素-1受体相关激酶1抗体
xy-3193R Phospho-IRAK1 (Thr209)磷酸化白介素-1受体相关激酶1抗体
xy-3194R Phospho-IRAK1 (Thr387)磷酸化白介素-1受体相关激酶1抗体
xy-2993R IRF3干扰素调节因子3
xy-3195R Phospho-IRF3 (Ser396)磷酸化干扰素调节因子3
xy-2994R IRF7干扰素调节因子7抗体
xy-3196R Phospho-IRF7 (Ser471 + Ser472)磷酸化干扰素调节因子7抗体
xy-3198R phospho-IRS1(Ser302)磷酸化胰岛素受体底物-1抗体
xy-3199R phospho-IRS1(Ser332 + Ser336)磷酸化胰岛素受体底物-1抗体
xy-3200R phospho-IRS1(Ser612)磷酸化胰岛素受体底物-1抗体
xy-3203R phospho-IRS1(Tyr1222)磷酸化胰岛素受体底物-1抗体
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验乙型肝炎、和HBsAg阳性的患者血清中前S1蛋白,前S1抗原阴转愈早,AHB患者的疗程愈短,预后也愈好。说明前S1抗原及其抗体的检测是急性乙型肝炎的临床诊断,疗效观察和判数据预后的良好指标。 前S1蛋白的分子生物学特性 1.乙肝病毒(HBV)的基因结构 HBV为嗜肝DNA病毒,由一个不完全双链DNA组成,约3200个氨基酸。长链L含4个开放读码框架,为病毒蛋白的编码区:S区、C区、P区、X区。短链S相当于长链的50%-100%,其不固定端可被内原性DNA多聚酶延长,使病毒成为完整
纤维素薄膜)上,固相载体以非共价键形式吸附蛋白质,且能保持电泳分离的多肽类型及其生物学活性不变。以固相载体上的蛋白质或多肽作为抗原,与对应的抗 体起免疫反应,再与酶或同位素标记的第二抗体起反应,经过底物显色或放射自显影以检测电泳分离的特异性目的基因表达的蛋白成分。该技术也广泛应用于检测蛋 白水平的表达。二、分类western显色的方法主要有以下几种:i. 放射自显影ii. 底物化学发光ECLiii. 底物荧光ECFiv. 底物DAB呈色现 常用的有底物化学发光ECL和底物DAB呈色,体同水平和实验
,“显色”用标记的二抗。经过PAGE分离的蛋白质样品,转移到固相载体(例如硝酸纤维素薄膜)上,固相载体以非共价键形式吸附蛋白质,且能保持电泳分离的多肽类型及其生物学活性不变。以固相载体上的蛋白质或多肽作为抗原,与对应的抗体起免疫反应,再与酶或同位素标记的第二抗体起反应,经过底物显色或放射自显影以检测电泳分离的特异性目的基因表达的蛋白成分。该技术也广泛应用于检测蛋白水平的表达。二、分类现常用的有底物化学发光ECL和底物DAB呈色,体同水平和实验条件的是用第一种方法,目前发表文章通常是用底物化学发光ECL
技术资料暂无技术资料 索取技术资料





